Skip to main content
. 2011 Aug 27;378(9793):771–784. doi: 10.1016/S0140-6736(11)60993-8

Figure 3.

Figure 3

Relevance of nodal status and of background chemotherapy to the effects of tamoxifen on the 10-year probability of recurrence, for ER-positive disease

Outcome by allocated treatment in trials of about 5 years of adjuvant tamoxifen. Event rate ratio (RR) is from summed log-rank statistics for all time periods. Gain (and its SE) is absolute difference between ends of graphs. ER=oestrogen receptor. PR=progesterone receptor. O–E=observed minus expected, with variance V.